Transthyretin Methionine-30 Amyloidosis - Medical Condition Information

Transthyretin Methionine-30 Amyloidosis

Type I Amyloidosis

📋Overview

Transthyretin Methionine-30 Amyloidosis is a hereditary form of transthyretin amyloidosis (ATTR amyloidosis) caused by a mutation substituting methionine at position 30 of the transthyretin (TTR) protein. It is a variant of hereditary ATTR amyloidosis, a condition characterized by abnormal amyloid protein deposits derived from mutated transthyretin, leading to progressive organ dysfunction, primarily affecting peripheral nerves and the heart.

🛡️ Educational information only

This content is provided for general health education and awareness and is based on publicly available medical information. It is not intended to replace professional medical advice, diagnosis, or treatment, and should not be used to make healthcare decisions. Always seek the guidance of a qualified healthcare professional regarding any medical condition, medication, supplement, or procedure.

🧠User experience scores: Not enough reports yetShare your experience
Sections:

Additional Resources

Share

Overall Community Experience

No experiences shared yet — be the first to share your experience.

Shared experiences are personal and do not replace medical advice.

Share Your Experience with Transthyretin Methionine-30 Amyloidosis

Answer each question one at a time. Your full experience is submitted only after the last question. Responses are anonymous.

Step 1 of 80/7 rated

Overall Impact on Daily Life

How much did this condition affect your daily life? (Work, school, sleep, social life, daily activities)

No impactCompletely disruptive

One question at a time · submitted at the end

Found an Error?

Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.

Healthcare professional? Explore income opportunities